Published in Med Oncol Tumor Pharmacother on January 01, 1992
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. J Virol (2006) 1.44
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiol (2012) 1.28
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J Virol (2009) 1.20
Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy. J Virol (2010) 1.07
Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther (2009) 1.04
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine. Mol Ther (2012) 1.03
Oncolysis by paramyxoviruses: preclinical and clinical studies. Mol Ther Oncolytics (2015) 0.95
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. Cancer Gene Ther (2014) 0.88
Safety and clinical usage of newcastle disease virus in cancer therapy. J Biomed Biotechnol (2011) 0.87
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host. Biology (Basel) (2013) 0.86
Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer. J Mol Med (Berl) (2010) 0.85
Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma. Viruses (2015) 0.84
Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data. Hum Gene Ther (2015) 0.83
Oncolytic viruses. Invest New Drugs (1999) 0.81
Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate! Biomedicines (2016) 0.77
Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer. Mol Ther Oncolytics (2014) 0.77
Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model. Mol Ther Oncolytics (2016) 0.75
Arginine deiminase system and bacterial adaptation to acid environments. Appl Environ Microbiol (1987) 2.03
Economy of water, carbon, and nitrogen in the developing cowpea fruit. Plant Physiol (1985) 1.73
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography. Radiology (1990) 1.65
Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg (1997) 1.61
beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation (2000) 1.37
Nitrogen nutrition and metabolic interconversions of nitrogenous solutes in developing cowpea fruits. Plant Physiol (1985) 1.23
Endoscopic techniques in aesthetic breast surgery. Augmentation, mastectomy, biopsy, capsulotomy, capsulorrhaphy, reduction, mastopexy, and reconstructive techniques. Clin Plast Surg (1995) 1.02
Hyperammonaemia and spongy degeneration of the brain in sheep affected with hepatic necrosis. Res Vet Sci (1974) 0.97
Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med (1997) 0.96
Immunofluorescent localization of urease in the cotyledons of jack bean, Canavalia ensiformis. J Cell Sci (1977) 0.91
Effect of tumor vaccines in immunizing patients with cancer. Surg Gynecol Obstet (1971) 0.90
Treatment of stage II malignant melanoma patients with a Newcastle disease virus oncolysate. Nat Immun Cell Growth Regul (1988) 0.90
Synthesis of proteolipid protein by yeast mitochondria. Biochem Biophys Res Commun (1972) 0.88
Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology (1996) 0.87
A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate. Cancer (1983) 0.85
Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap. Ann Surg Oncol (1996) 0.85
Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine. Clin Chem (1981) 0.84
Comparison of prophylactic and therapeutic castration in breast carcinoma. Surg Gynecol Obstet (1969) 0.83
Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate. Cancer (1986) 0.83
Immunotherapy for the patient with cancer. Ann Surg (1971) 0.81
Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg (2000) 0.81
Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses. Cancer (1977) 0.81
Mycotic abdominal aortic aneurysm induced by immunotherapy with bacille Calmette-Guérin vaccine for malignancy. J Vasc Surg (1988) 0.81
Granulomatous and neoplastic diseases of the skin of horses. Aust Vet J (1978) 0.80
Viral oncolysate in the management of malignant melanoma. II. Clinical studies. Cancer (1977) 0.79
Antitumor antibody in sera of immunized patients. Surg Forum (1969) 0.79
Melanoma of the external ear. J Surg Oncol (1992) 0.79
The influence of dietary ascorbic acid on the concentration of mercury in guinea-pig tissues [proceedings]. Proc Nutr Soc (1976) 0.77
Assessment of change in conventional and unconventional thought processes of schizophrenics. J Pers Assess (1974) 0.77
Plasma L-dopa in the diagnosis of malignant melanoma. Clin Chem (1986) 0.76
Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancer. Arch Surg (1991) 0.76
A segmental approach to computerized tomographic portography for hepatic resection. Surg Gynecol Obstet (1990) 0.75
Light-induced development of enzymes of glycollate metabolism in etiolated bean leaves. Biochem J (1971) 0.75
Potential value of cyclic 3'-5' nucleotide levels in circulating mononuclear cells of cancer patients in evaluation of immunocompetence. Cell Mol Biol Incl Cyto Enzymol (1979) 0.75
Metastatic phycomycosis in a horse. J Am Vet Med Assoc (1978) 0.75
A sensitive colorimetric assay for ribonuclease. Tex Rep Biol Med (1970) 0.75
Immunotherapy in malignant melanoma. J Clin Oncol (1999) 0.75
Acid Glycosidase Activities in the Cotyledons of Pisum sativum L. J Plant Physiol (2012) 0.75
Immunoglobulins associated with elevated riboflavin binding by plasma from cancer patients. Proc Soc Exp Biol Med (1986) 0.75
DSA evaluation of surgically implantable infusaid pump-catheter systems. AJR Am J Roentgenol (1986) 0.75
Whither immunocompetence? J Med Assoc Ga (1975) 0.75
British National Health Service. Can Med Assoc J (1956) 0.75
Immunotherapy of cancer in man. V. Studies of patients with primary and metastatic tumors of the lung. Am Surg (1972) 0.75
Studies of the use of tumor vaccine for the cancer patient. Bull Soc Int Chir (1973) 0.75
Desmoplastic spindle-cell melanoma of the eyelid with orbital invasion. Ophthal Plast Reconstr Surg (1999) 0.75
Ryanodine and left ventricular function in intact dogs: dissociation of force-based and velocity-based indexes. Am J Physiol (1997) 0.75
Immunotherapy of cancer in man. VII. Studies of patients with cancer of the alimentary tract. Am J Surg (1971) 0.75
Detection of myocardial ischemia. Curr Probl Cardiol (1995) 0.75
Photometabolism of glycollate by Euglena gracilis. Aust J Biol Sci (1971) 0.75